Dapagliflozin / Metformin Uses, Dosage, Side Effects and Interactions
Xigduo XR
Xigduo XR was the first dapagliflozin / metformin product the FDA approved, in October 2014. An FDA-approved generic with the same active ingredients is listed.
Dapagliflozin / Metformin is a two-medicine combination pill for adults with type 2 diabetes. It lowers blood sugar and, through dapagliflozin, can reduce the risk of kidney and heart problems.
Quick links
Ask Anything About Dapagliflozin / MetforminType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Dapagliflozin / Metformin in Short
- Drug classes Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor How the FDA classifies it
What it treatsDapagliflozin and metformin hydrochloride extended-release tablets are used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. The dapagliflozin part also lowers the risk of serious kidney and heart outcomes in adults with type 2 diabetes.
- How you get it Prescription only
- Comes asExtended-release tablet (by mouth)Available strengths (dapagliflozin/metformin)
- 2.5 mg/1000 mg
- 5 mg/500 mg
- 5 mg/1000 mg
- 10 mg/500 mg
- 10 mg/1000 mg
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Xigduo XR (tablet, extended release)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$0.47 to $0.80 a tablet
- Xigduo XR (brand)$9.59 to $19.24 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Dapagliflozin/metformin (Xigduo XR) is a common step up for type 2 diabetes when metformin alone is not enough. It pairs metformin, which lowers the sugar the liver makes, with dapagliflozin, which flushes extra sugar into the urine and lowers the risk of heart failure hospitalization and kidney decline in people who qualify; it has been around since about 2014, with FDA-approved generics listed. Most people handle it well, noticing mainly more frequent urination, some early stomach upset and genital yeast infections. Its boxed warning is lactic acidosis, a rare but life-threatening acid buildup from the metformin, so get emergency care for unexplained muscle pain, trouble breathing, unusual sleepiness or stomach pain.
Key Takeaways From the HelloPharmacist Team
- Take it once a day in the morning with food, and swallow the tablet whole without crushing, cutting or chewing it.
- Get urgent care for nausea, vomiting or stomach pain, since ketoacidosis (a dangerous acid buildup) can occur even without very high blood sugar.
- Expect kidney blood tests before starting and regularly after, and tell whoever schedules surgery or a contrast-dye scan that you take it.
- Drink enough fluids, especially in hot weather or when sick, since the extra urination can leave you dehydrated and dizzy.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Dapagliflozin / Metformin.
This medicine can cause lactic acidosis, a rare but life-threatening buildup of lactic acid in the blood. It has led to death in some cases.
Symptoms can be subtle: feeling unwell, muscle aches, trouble breathing, unusual sleepiness and stomach pain. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, contrast dye scans, surgery, low-oxygen states like acute heart failure, mitochondrial diseases, and certain medicines such as topiramate. If you suspect it, stop the medicine and get emergency care.
Patient Information Guide for Dapagliflozin / Metformin
What It’s Used For
This combination is for adults with type 2 diabetes.
- Improves blood sugar control along with diet and exercise.
- Lowers the risk of kidney function decline, end-stage kidney disease, cardiovascular death and heart failure hospitalization in chronic kidney disease at risk of progression.
- Lowers the risk of cardiovascular death, heart failure hospitalization and urgent heart failure visits in people with heart failure.
- Lowers the risk of heart failure hospitalization in people with established cardiovascular disease or multiple cardiovascular risk factors.
- Not for type 1 diabetes, and not for chronic kidney disease from polycystic kidney disease or after recent immunosuppressive therapy for kidney disease.
How It Works
Dapagliflozin blocks a protein in the kidneys called SGLT2, which normally pulls sugar back into the blood. Blocking it sends extra sugar out in the urine. It also affects sodium handling, which may ease strain on the heart and kidneys.
Metformin lowers sugar made by the liver, reduces sugar absorbed from the gut and helps your body use insulin better.
Drug Class
Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor from dapagliflozin
- Biguanide from metformin
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Dapagliflozin / Metformin has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Sodium-Glucose Cotransporter 2 Inhibitor from dapagliflozin
- Biguanide from metformin
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Sodium-Glucose Transporter 2 Inhibitors from dapagliflozin
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Dapagliflozin / Metformin in the FDA’s index.
From our Patient Information GuideDapagliflozin blocks a protein in the kidneys called SGLT2, which normally pulls sugar back into the blood. Blocking it sends extra sugar out in the urine. It also affects sodium handling, which may ease strain on the heart and kidneys. Metformin lowers sugar made by the liver, reduces sugar absorbed from the gut and helps your body use insulin better. Read How Dapagliflozin / Metformin Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Biguanides from metformin
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Combinations of oral blood glucose lowering drugs
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
This is an extended-release tablet taken by mouth once daily in the morning with food. Swallow it whole.
- Your prescriber chooses a starting dose based on what you take now and adjusts it as needed.
- Doses are increased gradually to ease stomach side effects.
- Your doctor may have you stop it before contrast dye imaging or for at least 3 days before surgery or procedures with prolonged fasting, if possible.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Blood sugar control in type 2 diabetes
Adults and children 10 and older · Starting dose of dapagliflozin Starting dose 5 mg once a day Highest dose 10 mg of dapagliflozin a day
- 5 mg orally once daily (dapagliflozin in Xigduo XR), in the morning with food
Good to know
Dosage may be adjusted based on effectiveness and tolerability
Adults and children 10 and older · Starting dose of metformin Starting dose 500 mg of metformin extended-release once a day Highest dose 2,000 mg of metformin extended-release a day
- 500 mg orally once daily (metformin HCl extended-release in Xigduo XR), in the morning with food
Good to know
Gradual dosage escalation to reduce gastrointestinal adverse reactions; patients taking an evening dosage of metformin HCl extended-release should skip their last dose before starting
Adults with heart failure or chronic kidney disease (dapagliflozin dosage)
Usual dose 10 mg of dapagliflozin once a day Highest dose 10 mg of dapagliflozin a dayOther Doses
Adults with mildly reduced kidney function (eGFR 45 or higher) Same as the recommended dosage in patients with normal renal function
Good to know
Initiation not recommended with eGFR between 30 and 45 mL/min/1.73 m2; contraindicated with eGFR below 30 mL/min/1.73 m2
eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.
Side Effects
Common side effects include:
Common side effects
- Genital yeast infections (more common in women, also seen in men)
- Urinary tract infections
- Diarrhea
- Nausea or vomiting
- Headache
- Stuffy or runny nose and sore throat (nasopharyngitis)
- Increased urination
When to get medical help
- Get emergency help for unusual muscle pain, extreme tiredness, trouble breathing, unusual sleepiness, stomach pain, or feeling cold or dizzy. These can be signs of lactic acidosis.
- Get help right away for nausea, vomiting, stomach pain, unusual tiredness or shortness of breath. These can signal ketoacidosis, even when blood sugar is not very high.
- Seek care right away for pain, tenderness, redness or swelling in the genital or buttock area with fever or feeling unwell. This can be a rare, serious infection (Fournier’s gangrene).
- Call your doctor about signs of dehydration or low blood pressure, such as dizziness or fainting.
- Call your doctor about signs of a urinary or genital infection.
- Seek help for a serious allergic reaction, such as swelling of the face or throat or trouble breathing.
Seek help quickly for signs of lactic acidosis, ketoacidosis, dehydration, a severe genital or perineal infection, or a serious allergic reaction.
Warnings and Precautions
- Lactic acidosis (boxed warning): rare but can be fatal. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, and contrast dye scans.
- Ketoacidosis: can happen even with near-normal blood sugar. Risk rises with illness, reduced eating, surgery, dehydration or alcohol misuse.
- Dehydration and low blood pressure, and in some cases acute kidney injury.
- Serious genital and urinary infections, including Fournier’s gangrene.
- Low blood sugar when used with insulin or sulfonylureas.
- Low vitamin B12 from metformin, so your doctor will check blood counts yearly.
Interactions
Tell your pharmacist about all your medicines. Key ones include:
- Alcohol: raises lactic acidosis risk.
- Topiramate, zonisamide, acetazolamide, dichlorphenamide: may raise lactic acidosis risk.
- Ranolazine, vandetanib, dolutegravir, cimetidine: can increase metformin levels.
- Insulin or sulfonylureas: higher risk of low blood sugar.
- Diuretics, corticosteroids, estrogens, birth control pills, thyroid products and other drugs that can raise blood sugar.
- Lithium: levels may fall.
- Urine glucose tests will read positive, so they can’t track your control.
Interactions Listed in the FDA-Approved Label
From the Dapagliflozin / Metformin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide)What happensThey often lower serum bicarbonate and cause non-anion gap, hyperchloremic metabolic acidosis, which may increase the risk of lactic acidosis.What to doConsider more frequent monitoring.
-
Drugs that reduce metformin clearance (ranolazine, vandetanib, dolutegravir, cimetidine; OCT2/MATE inhibitors)What happensThey could increase metformin exposure and may increase the risk of lactic acidosis.What to doConsider the benefits and risks of concomitant use.
-
AlcoholWhat happensAlcohol is known to potentiate the effect of metformin on lactate metabolism.What to doWarn patients against excessive alcohol intake.
-
Insulin or insulin secretagogues For example: sulfonylureaWhat happensThe risk of hypoglycemia may be increased.What to doConcomitant use may require lower doses of insulin or the insulin secretagogue.
-
Drugs affecting glycemic control (thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid)What happensThese drugs tend to produce hyperglycemia and may lead to loss of glycemic control.What to doObserve closely for loss of blood glucose control when started, and for hypoglycemia when withdrawn.
-
What happensConcomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations.What to doMonitor serum lithium concentration more frequently during initiation and dosage changes.
-
Positive urine glucose testWhat happensSGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests.What to doMonitoring glycemic control with urine glucose tests is not recommended; use alternative methods.
-
1,5-anhydroglucitol (1,5-AG) assayWhat happensMeasurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors.What to doMonitoring with the 1,5-AG assay is not recommended; use alternative methods.
Read the label’s full interactions text
7 DRUG INTERACTIONS Table 6: Clinically Relevant Interactions with Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets Carbonic Anhydrase Inhibitors Clinical Impact Topiramate or other carbonic anhydrase inhibitors (e.g., zonisamide, acetazolamide or dichlorphenamide) frequently causes a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with dapagliflozin and metformin hydrochloride extended-release tablets may increase the risk for lactic acidosis. Intervention Consider more frequent monitoring of these patients. Drugs that Reduce Metformin Clearance Clinical Impact Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2]/multidrug and toxin extrusion [MATE] inhibitors, such as ranolazine, vandetanib, dolutegravir, and cimetidine) could increase systemic exposure to metformin and may increase the risk for lactic acidosis. Intervention Consider the benefits and risks of concomitant use. Alcohol Clinical Impact Alcohol is known to potentiate the effect of metformin on lactate metabolism. Intervention Warn patients against excessive alcohol intake while receiving dapagliflozin and metformin hydrochloride extended-release tablets. Insulin or Insulin Secretagogues Clinical Impact The risk of hypoglycemia may be increased when dapagliflozin and metformin hydrochloride extended-release tablet is used concomitantly with insulin or insulin secretagogues (e.g., sulfonylurea). Intervention Concomitant use may require lower doses of insulin or the insulin secretagogue to reduce the risk of hypoglycemia. Drugs Affecting Glycemic Control Clinical Impact Certain drugs tend to produce hyperglycemia and may lead to loss of glycemic control.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use with severe kidney disease (eGFR below 30), end-stage kidney disease, metabolic acidosis or ketoacidosis, or a past serious allergy to its ingredients.
- Avoid with liver disease.
- Not recommended with mitochondrial diseases such as MELAS or MIDD.
- Not for type 1 diabetes.
- Not recommended in the second and third trimesters of pregnancy or while breastfeeding.
- Older adults have more low blood pressure and need more frequent kidney checks.
- Tell your doctor about dehydration, diuretic use, heart failure, or genital or urinary infections.
Overdose
Metformin overdose can cause lactic acidosis, which happened in about 32% of reported overdose cases. Call Poison Help at 1-800-222-1222 or seek emergency care. Hemodialysis may help remove metformin.
Half-Life and How Your Body Processes It
Food does not change the overall absorption of either medicine in this tablet. Dapagliflozin has a half-life of about 12.9 hours and is mostly broken down into an inactive form, then cleared mainly through the kidneys. Metformin is not metabolized by the liver and leaves the body unchanged in urine, with about 90% of absorbed drug cleared within 24 hours. That is why kidney function matters so much.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Dapagliflozin / Metformin: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Dapagliflozin / Metformin — the kind of thing our pharmacy team would talk through with you at the counter.
What is dapagliflozin / metformin used for?
How should I take dapagliflozin / metformin?
What side effects should I expect?
Can I drink alcohol while taking dapagliflozin / metformin?
Do I need to stop it before surgery or a scan with contrast dye?
Is dapagliflozin / metformin safe in pregnancy?
Is dapagliflozin / metformin available over the counter?
When was dapagliflozin / metformin first available?
Who makes dapagliflozin / metformin?
What is the brand name of dapagliflozin / metformin?
What is the generic name of Xigduo XR?
What drug class is dapagliflozin / metformin?
Is there a generic version of dapagliflozin / metformin?
What strengths does dapagliflozin / metformin come in?
How much does dapagliflozin / metformin cost?
Where can I read the dapagliflozin / metformin prescribing information (package insert)?
Can you crush dapagliflozin / metformin?
Is dapagliflozin / metformin gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Dapagliflozin / Metformin
Skip the scrolling. Ask in your own words and get an answer from Dapagliflozin / Metformin’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Dapagliflozin / Metformin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Dapagliflozin / Metformin on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Dapagliflozin / Metformin Forms and Strengths (How It Comes)
Dapagliflozin / Metformin comes in 1 dose form, the extended-release tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Dapagliflozin / Metformin inactive ingredients by manufacturer.
Extended-release tablet
How this form is used
- Dapagliflozin and Metformin Hydrochloride extended-release tablets are used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
- Dapagliflozin and Metformin Hydrochloride extended-release tablets also reduce the risk of kidney decline, cardiovascular death and heart failure hospitalization in certain adults with type 2 diabetes.
- Dapagliflozin and Metformin Hydrochloride extended-release tablets are taken by mouth once daily in the morning with food.
- Swallow Dapagliflozin and Metformin Hydrochloride extended-release tablets whole. Never crush, cut or chew them.
- If you take evening metformin extended-release, skip your last dose before starting Dapagliflozin and Metformin Hydrochloride.
Dapagliflozin / Metformin on the U.S. Market: Products, Makers and Brands
How Dapagliflozin / Metformin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
10 companies list 37 Dapagliflozin / Metformin product records with the FDA, mostly as extended-release tablet; the earliest marketing or approval year on record is 2014. The one brand name in the directory today is Xigduo XR; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated, extended release (5) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Dapagliflozin / Metformin Is Used (Medicaid Data)
How many Dapagliflozin / Metformin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Dapagliflozin / Metformin prescribed? Of the 1,682 medications we measure, Dapagliflozin / Metformin ranks #686 by Medicaid prescriptions — more than 59% of them.
Utilization by Dapagliflozin / Metformin product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
24 HR dapagliflozin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet Most dispensed
2 of 24 listed NDCs had Medicaid claims. RxNorm 1593070
24 HR dapagliflozin 10 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
2 of 23 listed NDCs had Medicaid claims. RxNorm 1593058
24 HR dapagliflozin 5 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet
1 of 16 listed NDCs had Medicaid claims. RxNorm 1593072
24 HR dapagliflozin 10 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet
1 of 20 listed NDCs had Medicaid claims. RxNorm 1593068
24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
1 of 3 listed NDCs had Medicaid claims. RxNorm 1940496
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 7 of the 86 listed Dapagliflozin / Metformin NDCs had Medicaid claims.
Compare Dapagliflozin / Metformin Products
A representative set of FDA-listed product records for Dapagliflozin / Metformin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 2.5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | AstraZeneca Pharmaceuticals LP | NDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | AstraZeneca Pharmaceuticals LP | NDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | AstraZeneca Pharmaceuticals LP | NDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | AstraZeneca Pharmaceuticals LP | NDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | AstraZeneca Pharmaceuticals LP | NDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 37 of 37 products — FDA National Drug Code Directory. See every product, package size and price: browse all 37 Dapagliflozin / Metformin NDCs →
Dapagliflozin / Metformin Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dapagliflozin / Metformin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dapagliflozin / Metformin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Dapagliflozin / Metformin FDA Approval History
How Dapagliflozin / Metformin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Dapagliflozin / Metformin Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Dapagliflozin / Metformin recalls since July 2021.
✅No Dapagliflozin / Metformin recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Dapagliflozin / Metformin in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 5
- Forms in current FDA listings
- 1 of 1
RxCUI 1486436 -
Dose form (SCDF) Extended Release Oral TabletIn current FDA listings
RxCUI 1593057Its 5 strengths (SCD)-
24 hr dapagliflozin 10 mg / metformin hydrochloride 1000 mg
RxCUI 1593058 -
24 hr dapagliflozin 10 mg / metformin hydrochloride 500 mg
RxCUI 1593068 -
24 hr dapagliflozin 2.5 mg / metformin hydrochloride 1000 mg
RxCUI 1940496 -
24 hr dapagliflozin 5 mg / metformin hydrochloride 1000 mg
RxCUI 1593070 -
24 hr dapagliflozin 5 mg / metformin hydrochloride 500 mg
RxCUI 1593072
-
24 hr dapagliflozin 10 mg / metformin hydrochloride 1000 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Dapagliflozin / Metformin Supply and Shortage Status
Whether Dapagliflozin / Metformin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Dapagliflozin / Metformin Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Dapagliflozin / Metformin: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.
At this strength, Xigduo XR costs pharmacies $9.59 per tablet.
For the generic DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg extended-release tablet, pharmacies paid an average of $0.469 per tablet as of Nov 18, 2026, down 92% from $5.84 a year earlier. At this strength, Xigduo XR costs pharmacies $9.59 per tablet.
- What pharmacies pay now
- $0.469
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 3.7%
- from $0.487 on Oct 21, 2026
- Last 12 months
- Down 92%
- from $5.84 on Nov 19, 2025
- Lowest and highest since Apr 2024
- $0.461 to $5.92
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.469 |
| Oct 2026 | $0.487 |
| Sep 2026 | $0.461 |
| Aug 2026 | $0.475 |
| Jul 2026 | $0.475 |
| Jun 2026 | $5.83 |
| May 2026 | $5.84 |
| Apr 2026 | $5.88 |
| Mar 2026 | $5.90 |
| Feb 2026 | $5.90 |
| Jan 2026 | $5.86 |
| Dec 2025 | $5.85 |
| Nov 2025 | $5.84 |
| Oct 2025 | $5.87 |
| Sep 2025 | $5.89 |
| Aug 2025 | $5.91 |
| Jul 2025 | $5.92 |
| Jun 2025 | $5.90 |
| May 2025 | $5.87 |
| Apr 2025 | $5.86 |
| Mar 2025 | $5.83 |
| Feb 2025 | $5.78 |
| Jan 2025 | $5.75 |
| Dec 2024 | $5.77 |
| Nov 2024 | $5.77 |
| Oct 2024 | $5.84 |
| Sep 2024 | $5.83 |
| Aug 2024 | $5.85 |
| Jul 2024 | $5.67 |
| Jun 2024 | $5.66 |
| May 2024 | $5.57 |
| Apr 2024 | $5.54 |
See all 11 prices in a table
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 2.5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Xigduo XR (brand) | $9.62 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Generic | $0.718 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Generic | $0.469 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Xigduo XR (brand) | $19.17 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Generic | $0.469 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Xigduo XR (brand) | $9.59 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Generic | $0.736 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Generic | $0.802 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Xigduo XR (brand) | $19.24 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Generic | $0.802 per tablet | NDC details & price history |
| Extended-release tablet · Oral | DAPAGLIFLOZIN PROPANEDIOL 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg | Xigduo XR (brand) | $19.20 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Dapagliflozin / Metformin Brand Names
Dapagliflozin / Metformin has one brand name on record: Xigduo XR. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Dapagliflozin / Metformin: Manufacturers and Labelers
10 companies list Dapagliflozin / Metformin products with the FDA. By number of product records, the largest are AstraZeneca Pharmaceuticals LP, Ascend Laboratories, LLC, Aurobindo Pharma Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Dapagliflozin / Metformin Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Aurobindo Pharma Limited is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →